Wednesday, June 5, 2019 Study Illuminates Serious but Treatable Lung Autoimmunity in APECED 3D-reconstructed chest CT images of a person with APECED pneumonitis before (left) and one month after (right) starting treatment. Green indicates lung abnormalities. Credit: NIAID Autoimmune lung inflammation, or pneumonitis, is a common, early and often-overlooked symptom of the rare disorder APECED, a new NIAID-led study has revealed. If untreated, APECED pneumonitis can cause severe, life-threatening lung damage. The study results, published today in Science Translational Medicine, illuminate the immune responses involved in APECED pneumonitis and provide early evidence for a promising treatment strategy. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107